2. UroToday Home
  3. Recent Abstracts
  4. COVID-19 and Genitourinary Cancers

The COVID-19 & Cancer Consortium (CCC19): A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer

Summary

National and international consortia will play a key role in understanding the effects of the coronavirus disease 2019 (COVID-19) pandemic on cancer patients. The COVID-19 & Cancer Consortium (CCC19) aims to collect and analyze observational data at scale to inform clinical practice in real-time.

Read the Full-Text


Samuel Rubinstein,1 John A. Steinharter,2 Jeremy Warner,1,3 Brian I. Rini,1 Solange Peters,4 Toni K. Choueiri2,5 *

  1. Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN
  2. Department of Medical Oncology, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA
  3. Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN
  4. Oncology Department, Lausanne University Hospital, Lausanne, Switzerland 5Brigham and Women’s Hospital and Harvard Medical School, Boston, MA *Corresponding author:
Source: Rubinstein, S., Steinharter, J., Warner, J., Rini, B., Peters, S., & Choueiri, T. (2020). The COVID-19 & Cancer Consortium (CCC19): a collaborative effort to understand the effects of COVID-19 on patients with cancer. Cancer Cell. doi: 10.1016/j.ccell.2020.04.018

Related Content: 

View: COVID-19 and Cancer Consortium (CCC19) - Jeremy Warner -Ali Khaki - Petros Grivas

View: Considerations of GU Cancer Patients Treatments in the New Reality of COVID-19 - Petros Grivas
View: Navigating GU Oncology Care during the COVID-19 Pandemic - Petros Grivas